Ming-Ming Zhou

This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (May 2019) (Learn how and when to remove this message)

Ming-Ming Zhou
Nationality	American
Alma mater	East China University of Science and Technology Michigan Technological University Purdue University
Known for	Bromodomain biology and drug discovery
Scientific career
Fields	Structural and Chemical Biology Epigenetics Drug Discovery
Institutions	Icahn School of Medicine at Mount Sinai Mount Sinai Medical Center

Ming-Ming Zhou is an American scientist whose specification is structural and chemical biology, NMR spectroscopy, and drug design. He is the Dr. Harold and Golden Lamport Professor and Chairman of the Department of Pharmacological Sciences.^[1] He is also the co-director of the Drug Discovery Institute at the Icahn School of Medicine at Mount Sinai and Mount Sinai Health System in New York City, as well as Professor of Sciences.^[2] Zhou is an elected fellow of the American Association for the Advancement of Science.^[3]

Zhou has published more than 180 research articles and is an inventor of 28 patents. His research has been funded by grants from federal, state and private research foundations including: the National Institutes of Health, the National Science Foundation, the New York State Stem Cell Science, the Institute for the Study of Aging, the American Foundation for AIDS Research, the American Cancer Society, GlaxoSmithKline, the Michael J. Fox Foundation, the Samuel Waxman Cancer Research Foundation,^[4] and the Wellcome Trust. He serves on the board of directors at the New York Structural Biology Center, as well as on the editorial boards of ACS Medicinal Chemistry Letters, the Journal of Molecular Cell Biology,^[5] and Cancer Research.^[6]